ECM
IGC icon

ExodusPoint Capital Management’s IGC Pharma IGC Stock Holding History

ExodusPoint Capital Management’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,049
Closed -$7K – 2079
2022
Q2 		$7K Buy
+13,049
New +$8.23K ﹤0.01% 1869

Other funds holding IGC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

ExodusPoint Capital Management's IGC Position: Q3 2022 in Review

ExodusPoint Capital Management sold out of IGC Pharma (IGC) in Q3 2022, closing a stake of 13,049 shares — an estimated $7K sold.

ExodusPoint Capital Management first reported a position in IGC in Q2 2022 and held it in 1 quarter. The position peaked at $7K in Q2 2022. 26 funds tracked by Wall St. Rank hold IGC as of Q3 2022.

  • ExodusPoint Capital Management reported no remaining IGC Pharma position as of Q3 2022 after selling out during the quarter.
  • ExodusPoint Capital Management sold 13,049 IGC Pharma shares in Q3 2022, an estimated $7K.
  • ExodusPoint Capital Management first reported a position in IGC Pharma in Q2 2022 and held it in 1 quarter.
  • ExodusPoint Capital Management's IGC Pharma position peaked at $7K in Q2 2022.
  • 26 funds tracked by Wall St. Rank held IGC Pharma as of Q3 2022.

Based on ExodusPoint Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.